GlaxoSmithKline
Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhoea
11 Aug 2025
Submission supported by positive phase III data in patients with uncomplicated urogenital gonorrhoea in EAGLE 1 trial
GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation
08 Aug 2025
CureVac will make an upfront settlement of $370 million to GSK
GSK highlights new findings on Dementia and Alzheimerâs Disease at AAIC 2025, building on leadership in immunology and inflammation
29 Jul 2025
Real-world data shows an association between Recombinant Zoster Vaccine (RZV) and potential reduced risk of dementia.
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
28 Jul 2025
Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPD
Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractory multiple myeloma
28 Jul 2025
Sixth regulatory approval for Blenrep combinations with applications under review in all major markets
GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab mafodotin-blmf) in relapsed/refractory multiple myeloma
23 Jul 2025
New PDUFA date scheduled for 23 October 2025.
GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/refractory multiple myeloma
18 Jul 2025
The US FDA Oncologic Drugs Advisory Committee voted against the proposed dosage of Blenrep (belantamab mafodotin-blmf) combinations.
US FDA approves GSKâs Shingrix in a prefilled syringe presentation
17 Jul 2025
Prefilled syringe presentation offers a convenient administration option to healthcare professionals
ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment
16 Jul 2025
Agreement allows manufacturers to develop, manufacture and supply generic LA injectable cabotegravir for treatment in 133 countries.
Featured
Typewriters, the office machines that preceded computers
By Kiron Kasbekar | 10 Apr 2025
You see office tables today equipped with desktop computers or laptops. But think of the 1970s, and what would you have been seeing?
Wishful thinking about cars
By Kiron Kasbekar | 05 Apr 2025
Donald Trump may be many things, but a good economist he is not. Accustomed to dictating terms to people he has worked with,
The history of safety glass
By Kiron Kasbekar | 26 Mar 2025
You probably already knew that the world’s VIPs move around in cars with bullet-proof glass windscreen and windows. But did you know that ‘bulletproof glass’ is not really bulletproof?
German silver: used in cutlery, music, electricals - but it’s not silver
By Kiron Kasbekar | 20 Mar 2025
This material, which was first developed in China, not Germany, and is an alloy of copper, nickel and zinc, has lost its sheen in home uses, but finds favor in electrical engineering.
Pioneers – the Wrights and Glenn Curtiss launched the aircraft industry
By Kiron Kasbekar | 17 Mar 2025
First Orville and Wilbur Wright flew their plane, the ‘Wright Flyer’, from near a small town called Kitty Hawk. Then Glenn Curtiss built planes with a very different system of controls, which has lasted until now.
What do aircraft have in common with bicycles and motorcycles?
By Kiron Kasbekar | 17 Mar 2025
From chains and sprockets to direct drives—If someone asked you what aircraft have in common with bicycles and motorcycles, how would you respond?
Radar’s ancestors: From sound mirrors to modern detection technology
By Kiron Kasbekar | 11 Mar 2025
Radar has become a well-settled technology today, especially in the field of navigation.
Nokia Bell Labs: innovations in communication, computing, technology
By Omar Almeida | 08 Mar 2025
Bell Laboratories, or Bell labs, which has now become Nokia Bell Labs, is one of the most renowned research and development organizations in the history of science and technology.
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
